SC
RVMDW icon

Sculptor Capital’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Sculptor Capital’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.66M Sell
709,670
-249,152
-26% -$1.35M 0.05% 183
2026
Q1 		$1.7M Buy
958,822
+780,715
+438% +$1.51M 0.02% 241
2025
Q4 		$163K Hold
178,107
– – ﹤0.01% 324
2025
Q3 		$50.3K Hold
178,107
– – ﹤0.01% 327
2025
Q2 		$41.8K Hold
178,107
– – ﹤0.01% 338
2025
Q1 		$9.5K Hold
178,107
– – ﹤0.01% 306
2024
Q4 		$30.3K Hold
178,107
– – ﹤0.01% 291
2024
Q3 		$25.8K Hold
178,107
– – ﹤0.01% 281
2024
Q2 		$18.3K Hold
178,107
– – ﹤0.01% 274
2024
Q1 		$33.8K Hold
178,107
– – ﹤0.01% 254
2023
Q4 		$61K Buy
+178,107
New +$79.6K ﹤0.01% 256

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $21.5B AUM 81.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Sculptor Capital's RVMDW Position: Q2 2026 in Review

Sculptor Capital reduced its Revolution Medicines Inc Warrant (RVMDW) stake by 26% in Q2 2026, selling an estimated $1.35M and leaving 709,670 shares worth $6.66M. The position accounts for 0.05% of the portfolio, ranked #183.

Sculptor Capital first reported a position in RVMDW in Q4 2023 and has held it in 11 quarters since. 22 funds tracked by Wall St. Rank hold RVMDW as of Q2 2026.

  • Sculptor Capital held 709,670 shares of Revolution Medicines Inc Warrant worth $6.66M as of Q2 2026.
  • Sculptor Capital sold 249,152 Revolution Medicines Inc Warrant shares in Q2 2026, an estimated $1.35M.
  • Revolution Medicines Inc Warrant made up 0.05% of Sculptor Capital's portfolio in Q2 2026, its #183 holding.
  • Sculptor Capital first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and has held it in 11 quarters since.
  • 22 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q2 2026.

Based on Sculptor Capital's 13F filing for Q2 2026, filed 14 Aug 2026.